Gilead Sciences
GILD
#131
Rank
NZ$281.45 B
Marketcap
NZ$226.69
Share price
3.26%
Change (1 day)
27.62%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2025 (TTM): NZ$16.76 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are NZ$29.44 Billion. , an increase over its 2024 earnings that were of NZ$1.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2025

Annual earnings

Year Earnings Change
2025 NZ$17.36 B1319.86%
2024 NZ$1.22 B-89.94%
2023 NZ$12.15 B17.97%
2022 NZ$10.30 B-29.77%
2021 NZ$14.67 B395.99%
2020 NZ$2.95 B-67.66%
2019 NZ$9.14 B-33.84%
2018 NZ$13.82 B-42.35%
2017 NZ$23.98 B-20.87%
2016 NZ$30.30 B-21.06%
2015 NZ$38.39 B45.8%
2014 NZ$26.33 B253.01%
2013 NZ$7.45 B16.51%
2012 NZ$6.40 B-1.07%
2011 NZ$6.47 B-6.71%
2010 NZ$6.93 B11.75%
2009 NZ$6.20 B29.5%
2008 NZ$4.79 B19.11%
2007 NZ$4.02 B-455.74%
2006 -NZ$1.14 Billion-154.93%
2005 NZ$2.05 B76.99%
2004 NZ$1.16 B-266.16%
2003 -NZ$0.71 Billion-638.24%
2002 NZ$0.13 B31.5%
2001 NZ$98.94 M-242.15%
2000 -NZ$69.61 Million-40.2%
1999 -NZ$0.12 Billion31.85%
1998 -NZ$88.29 Million8.73%
1997 -NZ$81.19 Million27.22%
1996 -NZ$63.82 Million
1994 -NZ$60.81 Million26.57%
1993 -NZ$48.05 Million46.49%
1992 -NZ$32.8 Million362.5%
1991 -NZ$7.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$46.05 B 165.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$18.77 B 8.10%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$11.69 B-32.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$55.17 B 217.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$16.10 B-7.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$2.87 B-83.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$2.05 B-88.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$8.97 B-48.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$23.31 B 34.25%๐Ÿ‡บ๐Ÿ‡ธ USA